Molecular typing is based on molecular genetic testing and is not but routinely readily available. Molecular subtypes and immunohistochemical surrogate markers of your tumors (HR, HER2, triple detrimental) correlate in about 70%. The differentiation of luminal A and B subtypes by HR standing and proliferation markers like Ki-67 may https://micks630iqx7.shopping-wiki.com/user